You are here

Eli Lilly

J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups

Fierce Pharma

Fri, 10/25/24 - 11:43 am

plaque psoriasis

atopic dermatits

How Lilly is building a brand people trust

Medical Marketing and Media

Thu, 10/24/24 - 08:20 pm

Weight-loss drugs didn't curb health costs within two years

Reuters

Thu, 10/24/24 - 11:11 am

Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market

Reuters

Thu, 10/24/24 - 09:53 am

Lilly's Alzheimer's drug gets UK nod, but no NHS funding

Pharmaphorum

Wed, 10/23/24 - 11:26 am

Alzheimer's disease

Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing'

Fierce Pharma

Tue, 10/22/24 - 11:32 pm

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

Pharma Voice

Mon, 10/21/24 - 09:37 am

On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study

Fierce Pharma

Tue, 10/15/24 - 10:15 am

Crohn's Disease

clinical trials

FDA, facing pressure, to review position on Zepbound, Mounjaro shortage

BioPharma Dive

Mon, 10/14/24 - 11:17 pm

Lilly picks UK for first European Gateway Lab as part of $364M investment plan

Fierce Biotech

Mon, 10/14/24 - 10:28 am

FDA to reconsider decision barring compounded versions of Lilly weight loss drug

Reuters

Sun, 10/13/24 - 11:33 am

compounded drugs

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Lilly names Mount Sinai scientist as first chief AI officer

BioPharma Dive

Wed, 10/9/24 - 09:05 pm

artificial intelligence

Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases

BioSpace

Wed, 10/9/24 - 09:46 am

Weight loss gold rush: Developers vie for next blockbuster treatment

Pharmaphorum

Tue, 10/8/24 - 09:45 am

Boehringer Ingelheim

Lilly's weight-loss drug removed from FDA's shortage list

Reuters

Thu, 10/3/24 - 10:06 am

High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project

Fierce Pharma

Wed, 10/2/24 - 11:27 am

medicine foundry

drug manufacturing

Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings

Forbes

Wed, 10/2/24 - 11:20 am

Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro

Beckers Hospital Review

Tue, 10/1/24 - 10:45 am

Radiopharma biotech Aktis sees Big Pharma backers return for $175M series B

Fierce Biotech

Mon, 09/30/24 - 09:40 am

radiopharmaceuticals

Pages